298 related articles for article (PubMed ID: 28729824)
1. Mouse Models of
Batra R; Lee CW
Front Cell Neurosci; 2017; 11():196. PubMed ID: 28729824
[TBL] [Abstract][Full Text] [Related]
2. Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
Sattler R; Traynor BJ; Robertson J; Van Den Bosch L; Barmada SJ; Svendsen CN; Disney MD; Gendron TF; Wong PC; Turner MR; Boxer A; Babu S; Benatar M; Kurnellas M; Rohrer JD; Donnelly CJ; Bustos LM; Van Keuren-Jensen K; Dacks PA; Sabbagh MN;
Neurol Ther; 2023 Dec; 12(6):1821-1843. PubMed ID: 37847372
[TBL] [Abstract][Full Text] [Related]
3. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
4. RNA Misprocessing in
Barker HV; Niblock M; Lee YB; Shaw CE; Gallo JM
Front Cell Neurosci; 2017; 11():195. PubMed ID: 28744202
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis underlying hexanucleotide repeat expansions in
Chong ZZ; Menkes DL; Souayah N
Rev Neurosci; 2024 Jan; 35(1):85-97. PubMed ID: 37525497
[TBL] [Abstract][Full Text] [Related]
6. Knock in of a hexanucleotide repeat expansion in the
Dong W; Zhang L; Sun C; Gao X; Guan F; Li J; Chen W; Ma Y; Zhang L
Animal Model Exp Med; 2020 Sep; 3(3):237-244. PubMed ID: 33024945
[TBL] [Abstract][Full Text] [Related]
7. Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD/ALS neurodegeneration and behaviors.
Ma L; Liang C; Wang J; Chang Q; Wang Y; Zhang W; Du Y; Sadan J; Chen JF
Hum Mol Genet; 2023 Apr; 32(8):1252-1265. PubMed ID: 36322143
[TBL] [Abstract][Full Text] [Related]
8. Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD.
Schmitz A; Pinheiro Marques J; Oertig I; Maharjan N; Saxena S
Front Cell Neurosci; 2021; 15():637548. PubMed ID: 33679328
[TBL] [Abstract][Full Text] [Related]
9. The exocyst subunit EXOC2 regulates the toxicity of expanded GGGGCC repeats in C9ORF72-ALS/FTD.
Halim DO; Krishnan G; Hass EP; Lee S; Verma M; Almeida S; Gu Y; Kwon DY; Fazzio TG; Gao FB
Cell Rep; 2024 Jun; 43(7):114375. PubMed ID: 38935506
[TBL] [Abstract][Full Text] [Related]
10. Somatic and intergenerational G4C2 hexanucleotide repeat instability in a human C9orf72 knock-in mouse model.
Kojak N; Kuno J; Fittipaldi KE; Khan A; Wenger D; Glasser M; Donnianni RA; Tang Y; Zhang J; Huling K; Ally R; Mujica AO; Turner T; Magardino G; Huang PY; Kerk SY; Droguett G; Prissette M; Rojas J; Gomez T; Gagliardi A; Hunt C; Rabinowitz JS; Gong G; Poueymirou W; Chiao E; Zambrowicz B; Siao CJ; Kajimura D
Nucleic Acids Res; 2024 Jun; 52(10):5732-5755. PubMed ID: 38597682
[TBL] [Abstract][Full Text] [Related]
11. Optogenetic control of GGGGCC repeat-containing RNA phase transition.
Li X; Lu S; Lu B; Sun X
Fundam Res; 2022 Nov; 2(6):843-850. PubMed ID: 38933387
[TBL] [Abstract][Full Text] [Related]
12. C9orf72-Associated Dipeptide Repeat Expansions Perturb ER-Golgi Vesicular Trafficking, Inducing Golgi Fragmentation and ER Stress, in ALS/FTD.
Sultana J; Ragagnin AMG; Parakh S; Saravanabavan S; Soo KY; Vidal M; Jagaraj CJ; Ding K; Wu S; Shadfar S; Don EK; Deva A; Nicholson G; Rowe DB; Blair I; Yang S; Atkin JD
Mol Neurobiol; 2024 May; ():. PubMed ID: 38722513
[TBL] [Abstract][Full Text] [Related]
13. Moderate intrinsic phenotypic alterations in
Lorenzini I; Alsop E; Levy J; Gittings LM; Lall D; Rabichow BE; Moore S; Pevey R; Bustos LM; Burciu C; Bhatia D; Singer M; Saul J; McQuade A; Tzioras M; Mota TA; Logemann A; Rose J; Almeida S; Gao FB; Marks M; Donnelly CJ; Hutchins E; Hung ST; Ichida J; Bowser R; Spires-Jones T; Blurton-Jones M; Gendron TF; Baloh RH; Van Keuren-Jensen K; Sattler R
Front Cell Neurosci; 2023; 17():1179796. PubMed ID: 37346371
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of C9orf72 GGGGCC repeat-associated non-AUG translation with purified human translation factors.
Ito H; Machida K; Hasumi M; Ueyama M; Nagai Y; Imataka H; Taguchi H
Sci Rep; 2023 Dec; 13(1):22826. PubMed ID: 38129650
[TBL] [Abstract][Full Text] [Related]
15. Toxic gain-of-function mechanisms in
Beckers J; Van Damme P
Autophagy; 2024 Apr; ():1-3. PubMed ID: 38615685
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective.
Fernandes SA; Douglas AG; Varela MA; Wood MJ; Aoki Y
J Nucleic Acids; 2013; 2013():208245. PubMed ID: 24349764
[TBL] [Abstract][Full Text] [Related]
17. A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD.
McCallister TX; Lim CKW; Terpstra WM; Alejandra Zeballos C M; Zhang S; Powell JE; Gaj T
bioRxiv; 2023 Dec; ():. PubMed ID: 38168370
[TBL] [Abstract][Full Text] [Related]
18.
Broce IJ; Sirkis DW; Nillo RM; Bonham LW; Lee SE; Miller BL; Castruita PA; Sturm VE; Sugrue LS; Desikan RS; Yokoyama JS
Front Neurosci; 2024; 18():1258996. PubMed ID: 38469573
[TBL] [Abstract][Full Text] [Related]
19.
Broce IJ; Sirkis DW; Nillo RM; Bonham LW; Lee SE; Miller B; Castruita P; Sturm VE; Sugrue LS; Desikan RS; Yokoyama JS
bioRxiv; 2023 Aug; ():. PubMed ID: 37503230
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
